Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Medical Center Etika Ambulatory For Specialized Outpatient Medical Care OOD

Research site

Bulgaria Ulitsa Tundzha 2, 4002 Plovdiv, Bulgaria

  • Hidradenitis · Chronic obstructive pulmonary disease · Chronic spontaneous urticaria
  • Adult patients

About Specializations

Medical Center Etika Ambulatory For Specialized Outpatient Medical Care OOD in Plovdiv, Bulgaria specialises in clinical trials of conditions such as Hidradenitis, Chronic obstructive pulmonary disease, Chronic spontaneous urticaria, Psoriasis, and other specialisations. This site conducts important research.

Main research areas of the site

Severe Eosinophilic Asthma

The medical center is at the forefront of research in Severe Eosinophilic Asthma, focusing on innovative treatments to manage this challenging condition. The center's research aims to improve patient outcomes by reducing the frequency and severity of asthma exacerbations.

  • Innovative Therapeutics
  • Patient-Centric Care Models
  • Advanced Diagnostic Techniques

Through its commitment to cutting-edge research, the center is contributing significantly to the development of new therapeutic options, enhancing the quality of life for patients with severe eosinophilic asthma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Tundzha 24002 PlovdivBulgaria
Open in maps ↗
Recruiting now
no trials
Conditions studied
4

More sites in PlovdivBulgaria

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Chronic obstructive pulmonary disease

Not recruiting

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Hidradenitis

Not recruiting

A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BFB759
  • Sponsor:Bluefin Biomedicine Inc.

Psoriasis

Not recruiting

Study on the Effects and Safety of Piclidenoson for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Piclidenoson
  • Sponsor:Can-Fite Biopharma Ltd.

Hidradenitis+1

Not recruiting

Study on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:INF904
  • Sponsor:InflaRx GmbH
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.